(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
    • Natural Health Products
    • Drugs
    • Medical Devices
    • Consumer Products
    • Technology
    • FDA Consulting
    • Health Canada Consultants
    • Regulatory Affairs
    • Pharmacovigilance Services
  • Innovation
  • Articles
  • Contact
Select Page
Update on Nitrosamine Impurities in Pharmaceutical Products

Update on Nitrosamine Impurities in Pharmaceutical Products

by Jennifer P | Jan 7, 2020 | Canadian Regulatory, Cosmetics, European Regulatory, Natural Health Products, OTC Drugs, Research/Science/Technology, U.S. Regulatory

Health Canada has updated its assessment requirements for Nitrosamines in pharmaceutical products. Nitrosamines are, defined by the World Health Organization, as “any molecule containing the nitroso functional group. These molecules are of concern because nitrosamine...
New Changes to Health Canada’s Cosmetic Ingredient Hotlist

New Changes to Health Canada’s Cosmetic Ingredient Hotlist

by Jennifer P | Dec 23, 2019 | Canadian Regulatory, Cosmetics, Natural Health Products, Research/Science/Technology, Uncategorized

Earlier this month, Health Canada released a list of new amendments to both the Restricted and Prohibited Cosmetic Ingredient Hotlists. The list included changes to the classification or conditions of use on four ingredients, all already present on the Cosmetic...
Health Canada Announces the Creation of a New Medical Devices Directorate

Health Canada Announces the Creation of a New Medical Devices Directorate

by Jennifer P | Dec 18, 2019 | Canadian Regulatory, Medical Devices, Research/Science/Technology, Uncategorized

Health Canada has announced the creation of a new Medical Devices Directorate (MDD). This was done in order to account for and accurately reflect the current medical device industry, which has evolved drastically over the past several years. The new Directorate will...
European Commission Adopts Major Changes to Titanium Dioxide Classification

European Commission Adopts Major Changes to Titanium Dioxide Classification

by Jennifer P | Nov 27, 2019 | Canadian Regulatory, Cosmetics, European Regulatory, Natural Health Products, Research/Science/Technology

Early last month the European Commission (EC) adopted the 14th adaptation to technical progress (ATP) of the Classification and Labelling (CLP) Regulation. Within this adaptation are 28 proposed changes to the harmonised classification and labelling of substances. One...
Everything You Need To Know About Animal Testing Bans: Where They Stand And Where They Are Headed

Everything You Need To Know About Animal Testing Bans: Where They Stand And Where They Are Headed

by Jennifer P | Nov 12, 2019 | Canadian Regulatory, Cosmetics, Natural Health Products, Research/Science/Technology, U.S. Regulatory

Animal testing is, quite possibly, one of the most controversial and widely debated ethical issues in the cosmetic, personal care and healthcare industries. It is an issue that has gained an immense amount of traction in recent years, and rightly so, with numerous...
« Older Entries

Recent Posts

  • Interferon Beta 1a: Potentially Promising Treatment for Covid-19
  • The Sunshine Vitamin: What, Where, and How Much?
  • A Risk-Based Approach to Site License Applications
  • COVID-19 and Vitamin D: Correlation or Coincidence?
  • New Canadian Cosmetic Ingredient Hotlist Updates

Recent Comments

    Archives

    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • Canadian Regulatory
    • Cosmetics
    • European Regulatory
    • Events/Company Updates
    • Innovation
    • Innovation
    • Medical Devices
    • Natural Health Products
    • OTC Drugs
    • Our View
    • Research/Science/Technology
    • U.S. Regulatory
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2020 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY

    Delsie Braganza

    Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all submissions made to Health Canada and the US FDA.

    Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS). When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

     


    Jennifer Porter

    Since joining the FPR team in 2011, Jennifer has become our VP/GM managing all staff and projects in the corporate portfolio. She is responsible for finance, accounting and all aspects of IT.

    Jennifer obtained an MBA from University of Redlands, located in Southern California and a B.A. in Psychology from Hawaii Pacific University. When not supporting the needs for her clients, Jennifer enjoys golfing, live music, and traveling.